Stock data
Corcept Therapeutics Incorporated (CORT)
Corcept Therapeutics Incorporated (CORT) reported revenue of US$761.41M and net income of US$99.65M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$761.41M | — | US$44.80M | US$99.65M | — |
| 2024 | US$675.04M | — | US$136.95M | US$141.21M | — |
| 2023 | US$482.38M | — | US$107.28M | US$106.14M | — |
| 2022 | US$401.86M | — | US$112.63M | US$101.42M | — |
| 2021 | US$365.98M | — | US$124.48M | US$112.51M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$256.15M | US$42.99M | — |
| 2026-03-31 | US$164.90M | -US$31.76M | — |
| 2025-12-31 | US$202.12M | US$24.29M | — |
| 2025-09-30 | US$207.64M | US$19.67M | — |
| 2025-06-30 | US$194.43M | US$35.15M | — |
| 2025-03-31 | US$157.21M | US$20.55M | — |
| 2024-12-31 | US$181.89M | US$30.75M | — |
| 2024-09-30 | US$182.55M | US$47.21M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.